Wearable diagnostics are poised to transform subjective, episodic measures of disease progression to quantified, continuous data streams, according to some industry experts.
The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.
The UK-based firm is developing its initial panel tests for Gram-negative bacteria with tests for Gram-positive bacteria and ...
Last week, readers were most interested in a story about QuidelOrtho's ongoing restructuring to support profitability.
The test will measure levels of the 14-3-3eta protein, which is used in the diagnosis and management of inflammatory diseases including rheumatoid arthritis.
The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.
NEW YORK – Lumea and Caris Life Sciences said on Thursday that they have agreed to make Caris' sequencing-based urology tools available through Lumea's BxLink digital pathology platform. Under the ...
Clinical Diagnostics Growth Drives Rise in Qiagen's Q3 Revenues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback